Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,104,451
-
Number of holders
-
222
-
Total 13F shares, excl. options
-
92,267,243
-
Shares change
-
-1,699,610
-
Total reported value, excl. options
-
$2,256,709,187
-
Value change
-
-$39,028,941
-
Put/Call ratio
-
97%
-
Number of buys
-
124
-
Number of sells
-
77
-
Price
-
$24.46
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q2 2024
As of 30 Jun 2024 MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) had 222 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 92,267,243 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Camber Capital Management LP, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, EARNEST PARTNERS LLC, GLENVIEW CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, and BANK OF AMERICA CORP /DE/.
This table shows 222 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.